BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Rexahn Pharmaceuticals, Inc. 

15245 Shady Grove Road
Suite 455
Rockville  Maryland  20850  U.S.A.
Phone: 240-268-5300 Fax: 240-268-5310


SEARCH JOBS








 Company News
Rexahn Pharmaceuticals, Inc. (RNN) Presents Data From Preclinical Studies Of RX-21101 4/21/2014 9:13:05 AM    More...
Rexahn Pharmaceuticals, Inc. (RNN) To Present Data On RX-3117 And RX-21101 At The 2014 American Association for Cancer Research Annual Meeting 4/2/2014 7:54:04 AM    More...
Rexahn Pharmaceuticals, Inc. (RNN) Reports Fourth Quarter And Full-Year 2013 Financial Results And Recent Highlights 3/24/2014 9:34:24 AM    More...
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The 2nd Annual Sachs Cancer Bio Partnering & Investment Forum In New York 3/17/2014 8:36:37 AM    More...
Rexahn Pharmaceuticals, Inc. (RNN) Announces Initial Results From Phase I Trial Of Supinoxintm (RX-5902) For Solid Cancer Tumors 3/11/2014 9:08:41 AM    More...
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The 26th Annual ROTH Conference 3/4/2014 8:17:39 AM    More...
Rexahn Pharmaceuticals, Inc. (RNN) Appoints Mark Carthy To Board Of Directors 3/3/2014 7:35:24 AM    More...
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The 16th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/4/2014 7:57:58 AM    More...
Rexahn Pharmaceuticals, Inc. (RNN) Announces $20 Million Registered Direct Offering 1/15/2014 8:54:38 AM    More...
Rexahn Pharmaceuticals, Inc. (RNN) Initiates Phase 2a Clinical Trial Of Archexin® In Patients With Metastatic Renal Cell Carcinoma 1/14/2014 9:51:16 AM    More...
12345678910...

//-->